RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
NLS Pharmaceutics Stock

NLS Pharmaceutics Liabilities 2024

NLS Pharmaceutics Liabilities

10.68 M USD

Ticker

NLSP

ISIN

CH0523961370

In 2024, NLS Pharmaceutics's total liabilities amounted to 10.68 M USD, a 78% difference from the 6 M USD total liabilities in the previous year.

NLS Pharmaceutics Aktienanalyse

What does NLS Pharmaceutics do?

NLS Pharmaceutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing NLS Pharmaceutics's Liabilities

NLS Pharmaceutics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating NLS Pharmaceutics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing NLS Pharmaceutics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

NLS Pharmaceutics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in NLS Pharmaceutics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about NLS Pharmaceutics stock

What is the level of liabilities of NLS Pharmaceutics this year?

NLS Pharmaceutics has a debt balance of 10.68 M USD this year.

What were the liabilities of NLS Pharmaceutics compared to the previous year?

The liabilities of NLS Pharmaceutics have increased by 78% increased compared to the previous year.

What are the consequences of high debt for investors of NLS Pharmaceutics?

High liabilities can pose a risk for investors of NLS Pharmaceutics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in NLS Pharmaceutics?

Low liabilities mean that NLS Pharmaceutics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of NLS Pharmaceutics affect the company?

An increase in liabilities of NLS Pharmaceutics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of NLS Pharmaceutics affect the company?

A decrease in the liabilities of NLS Pharmaceutics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of NLS Pharmaceutics?

Some factors that can influence the liabilities of NLS Pharmaceutics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of NLS Pharmaceutics so important for investors?

The liabilities of NLS Pharmaceutics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can NLS Pharmaceutics take to modify the liabilities?

To change its liabilities, NLS Pharmaceutics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does NLS Pharmaceutics pay?

Over the past 12 months, NLS Pharmaceutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, NLS Pharmaceutics is expected to pay a dividend of 0 USD.

What is the dividend yield of NLS Pharmaceutics?

The current dividend yield of NLS Pharmaceutics is .

When does NLS Pharmaceutics pay dividends?

NLS Pharmaceutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of NLS Pharmaceutics?

NLS Pharmaceutics paid dividends every year for the past 0 years.

What is the dividend of NLS Pharmaceutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is NLS Pharmaceutics located?

NLS Pharmaceutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von NLS Pharmaceutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of NLS Pharmaceutics from 12/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/2/2024.

When did NLS Pharmaceutics pay the last dividend?

The last dividend was paid out on 12/2/2024.

What was the dividend of NLS Pharmaceutics in the year 2023?

In the year 2023, NLS Pharmaceutics distributed 0 USD as dividends.

In which currency does NLS Pharmaceutics pay out the dividend?

The dividends of NLS Pharmaceutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von NLS Pharmaceutics

Our stock analysis for NLS Pharmaceutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NLS Pharmaceutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.